Indian Journal of Clinical and Experimental Ophthalmology
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Review Article
Author Details :
Volume : 10, Issue : 4, Year : 2024
Article Page : 627-633
https://doi.org/10.18231/j.ijceo.2024.110
Abstract
Autoimmune blistering diseases refer to a diverse group of conditions that primarily target the skin and mucosa. However, in some cases, other organ systems can be involved, depending on the specific pathophysiology of the disease. Owing to the increased possibility of blindness associated with delayed diagnosis and treatment, it is essential to be aware of and detect ocular manifestations of these diseases at an early stage. The present article discusses the various oral mucosal lesions encountered in daily practice with emphasis on the ocular manifestations of each lesion.
Keywords: Conjunctivitis, Ocular manifestations, Oral mucosal lesions, Vesiculobullous lesions.
How to cite : Bhateja S, Sachdeva A, Arora G, Malhotra V, Malhotra T, Ocular manifestations of oral mucosal lesions. Indian J Clin Exp Ophthalmol 2024;10(4):627-633
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
